SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Onconetix, Inc.
Date: May 2, 2025 · CIK: 0001782107 · Accession: 0000000000-25-004701

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 001-41294

Date
May 2, 2025
Author
Finance
Form
UPLOAD
Company
Onconetix, Inc.

Letter

Re: Onconetix, Inc. Preliminary Proxy Statement on Schedule 14A Filed April 18, 2025 File No. 001-41294 Dear Karina Fedasz:

May 2, 2025

Karina Fedasz Interim Chief Executive Officer Onconetix, Inc. 201 E. Fifth Street, Suite 1900 Cincinnati, OH 45202

We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.

Sincerely,
Division of Corporation
Finance
Office of Life Sciences
cc: Jessica Yuan

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 May 2, 2025

Karina Fedasz
Interim Chief Executive Officer
Onconetix, Inc.
201 E. Fifth Street, Suite 1900
Cincinnati, OH 45202

 Re: Onconetix, Inc.
 Preliminary Proxy Statement on Schedule 14A
 Filed April 18, 2025
 File No. 001-41294
Dear Karina Fedasz:

 We have completed our review of your filing. We remind you that the
company and
its management are responsible for the accuracy and adequacy of their
disclosures,
notwithstanding any review, comments, action or absence of action by the staff.

 Sincerely,

 Division of Corporation
Finance
 Office of Life Sciences
cc: Jessica Yuan
</TEXT>
</DOCUMENT>